SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-035292
Filing Date
2018-05-23
Accepted
2018-05-23 08:25:41
Documents
6
Period of Report
2018-05-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-14203_18k.htm 8-K 26239
2 EX-99.1 a18-14203_1ex99d1.htm EX-99.1 29559
3 GRAPHIC g142031mmi001.jpg GRAPHIC 2256
4 GRAPHIC g142031mmi002.jpg GRAPHIC 26944
5 GRAPHIC g142031mmi003.jpg GRAPHIC 25819
6 GRAPHIC g142031mmi004.jpg GRAPHIC 29066
  Complete submission text file 0001104659-18-035292.txt   173338
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 18854120
SIC: 2834 Pharmaceutical Preparations